Fresenius reported EUR10.51B in Loan Capital for its fiscal quarter ending in September of 2026.





Loan Capital Change Date
Akzo Nobel EUR 5.5B 1000K Sep/2026
Alcon AG USD 4.69B 41M Sep/2026
AstraZeneca USD 28.8B 2.79B Sep/2026
BASF EUR 17.31B 1.51B Sep/2026
Bayer EUR 37.7B 6.54B Sep/2026
Beiersdorf EUR 110M 7M Jun/2026
DaVita Healthcare Partners USD 10.66B 150.24M Jun/2026
Demant DKK 13.13B 5.86B Jun/2026
E.ON EUR 38.55B 2.02B Jun/2026
Essilor EUR 9.66B 190M Jun/2026
Fresenius EUR 10.51B 952M Sep/2026
Fresenius Medical Care EUR 5.15B 676.78M Sep/2026
Getinge SEK 9.09B 167M Jun/2026
Givaudan CHF 4.19B 448M Dec/2025
GlaxoSmithKline GBP 21.7B 7.75B Sep/2026
GN Store Nord DKK 7.72B 394M Sep/2026
GRIFOLS EUR 8.69B 1.52B Sep/2026
Hikma Pharmaceutical USD 1.49B 692M Dec/2025
Lonza CHF 3.88B 323M Dec/2025
Merck EUR 10.34B 866M Sep/2026
Novartis USD 38.38B 893M Sep/2026
Philips EUR 6.98B 669M Sep/2026
Roche Holding CHF 25.22B 2.21B Jun/2026
RWE EUR 7.57B 8.86B Jun/2026
Sanofi EUR 16.28B 1.63B Sep/2026
Smith & Nephew USD 3.21B 85M Jun/2026